Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina

Vaccine

Volumn 26, Issue 51, 2008, Pages 6577-6586

  Maradei, Eduardo ^b   La Torre, José ^a   Robiolo, Blanca ^a   Esteves, Jorge ^b   Seki, Cristina ^a   Pedemonte, Andrea ^b   Iglesias, Marcela ^a   D'Aloia, Ricardo ^b   Mattion, Nora ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Servicio Nacional de Sanidad y Calidad Agroalimentaria Argentina   (Argentina)

Author keywords

Alternative potency test; Foot and mouth disease; IpELISA; Vaccine potency

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARGENTINA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; COW; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINATION; VACCINE PRODUCTION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ARGENTINA; CATTLE; CATTLE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL VACCINES;

EID: 58149119796     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.033     Document Type: Article

References (36)

1. Domingo E., Escarmis C., Baranowski E., Ruiz-Jarabo C.M., Carrillo E., Nunez J.I., et al. Evolution of foot-and-mouth disease virus. Virus Res 91 (2003) 47-63
2. Sutmoller P., Barteling S., Casas Olascoaga R., and Sumption K.J. Control and eradication of foot-and-mouth disease. Virus Res 91 (2003) 101-144
3. Grubman M.J., and Baxt B. Foot-and-mouth disease. Clin Microbiol Rev 17 2 (2004) 465-493
4. Barnett P.V., Samuel A.R., and Statham R.J. The suitability of the "emergency" foot-and-mouth disease antigens held by the international vaccine bank within a global context. Vaccine 19 (2001) 2107-2117
5. OIE (Office International des Epizooties). Foot and Mouth Disease. OIE Standards Commission. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 5th ed., Paris, France: Office International des Epizooties; 2004 [Chapter 2.1.1].
6. Pay T.W.F., and Parker N.J. Some statistical and experimental design problems in the assessment of FMDV vaccine potency. Dev Biol Stand 35 (1977) 369-383
7. Stellmann C., Bornarel P., Lang R., and Terre J. Controle quantitatif du vaccin antiaphtheux Analyse statistique de la relation liant les titers d'anticorps neutralisant au pourcentage de protection bovine. Rec Med Vet (Alfort) 144 (1968) 325-351
8. Goris N., Merkelbach-Peters P., Diev V.I., Verloo D., Zakharov V.M., Kraft H.P., et al. European pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences. Vaccine 25 (2007) 3373-3379
9. Vianna Filho Y.L., Astudillo V., Gomes I., Fernández G., Rozas C.E.E., Ravison J.A., et al. Potency control of foot-and-mouth disease vaccine in cattle. Comparison of the 50% protective dose and the protection against generalization. Vaccine 11 (1993) 1424-1428
10. Sutmöller P., and Vieira A. Relación de títulos de anticuerpos neutralizantes y la protección de bovinos frente al virus de la fiebre aftosa. Bol Cent Panamer Fiebre Aftosa 39-40 (1980) 51-56
11. Sutmöller P., Gomes I., and Astudillo V.M. Estimación de potencia de vacunas contra la fiebre aftosa de acuerdo con los resultados de pruebas de anticuerpos. Bol CentPanamer Fiebre Aftosa 49-50 (1984) 27-30
12. Pay T.W.F., and Hingley P.J. The use of serum neutralising antibody assay for the determination of the potency of foot-and-mouth disease vaccines in cattle. Dev Biol Stand 64 (1986) 153-161
13. Ahl R., Haas B., Lorenz R.J., and Wittman G. Alternative potency test of FMD vaccines and results of comparative antibody assays in different cell systems and ELISA. Report of the Meeting of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease. Lindholm, Denmark, June (1990), FAO, Rome 51-60
14. Pay T.W.F., and Hingley P.J. Foot-and-mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge. Vaccine 10 (1992) 699-706
15. Van Maanen C., and Terpstra C. Comparison of a liquid-phase blocking sandwich ELISA and serum neutralization test to evaluate immunity in potency tests of FMDV vaccines. J Immunol Methods 124 1 (1989) 111-119
16. Amadori M., Archetti I.L., Tollis M., Buonavoglia C., and Panina G.F. Potency assessment of foot and mouth disease vaccines in cattle by means of antibody assays. Biologicals 19 (1991) 191-196
17. Goris N., Willems T., Diev V., Merkelbach-Peters P., Vanbinst T., Van der Stede Y., et al. Indirect foot-and-mouth disease potency testing based on a serological alternative. Vaccine 26 (2008) 3870-3879
18. Periolo O.H., Seki C., Grigera P.R., Robiolo B., Fernandez G., Maradei E., et al. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina. Vaccine 11 (1993) 754-760
19. Robiolo B., Grigera P.R., Periolo O.H., Seki C., Bianchi T., Maradei E., et al. Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina. Vaccine 13 (1995) 1346-1352
20. Mattion N., König G., Seki C., Smitsaart E., Maradei E., Robiolo B., et al. Reintroduction of foot-and-mouth disease in Argentina: characterization of the isolates and development of tools for the control and eradication of the disease. Vaccine 22 (2004) 4149-4162
21. Robiolo B., Seki C., Fondevilla N., Grigera P., Scodeller E., Periolo O., et al. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA. Vaccine 24 (2006) 997-1008
22. Goris N., Maradei E., D'Aloia R., Fondevila N., Mattion N., Perez A., et al. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test. Vaccine 26 (2008) 3432-3437
23. Animal Health Service (SENASA). Act no. 351/2006. In: Boletín Oficial no. 30.940, Argentina, July 5th, 2006 [available at http://infoleg.mecon.gov.ar/infolegInternet/anexos/115000-119999/117636/norma.htm].
24. Office International des Epizooties. List of Foot and Mouth Disease free countries. Resolution no. XXI [available at http://www.oie.int/eng/info/en_fmd.htm?e1d6#Liste; updated August 9, 2007].
25. Bergmann I.E., Malirat V., Neitzert E., Beck E., Panizzutti N., Sanchez C., et al. Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot assay. Arch Virol 145 3 (2000) 473-489
26. Hamblin C., Barnett I.T.R., and Crowther J.R. A new enzyme linked immunosorbent assay (ELISA) for the detection of antibodies against FMDV. I. Development of a method for ELISA. J Immunol Methods 93 (1986) 115-121
27. Hamblin C., Barnett I.T., and Crowther J.R. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application. J Immunol Methods 93 1 (1986) 123-129
28. Hamblin C., Kitching R.P., Donaldson I., and Crowther J.R. Barnett ITR Enzyme-linked immunosorbent assay for the detection of antibodies against FMDV. III. Evaluation of antibodies after infection and vaccination. Epidemiol Infect 99 (1987) 733-744
29. Jacobson R.H. Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech Off Int Epiz 17 (1998) 469-486
30. Pan-American Foot-and-Mouth Disease Center. Report on the "Subproyecto para la correlación de las técnicas de control de potencia de las vacunas contra la Fiebre Aftosa en los países de la Cuenca del Río de la Plata". Rio de Janeiro, Brazil: PANAFTOSA; 1994.
31. Trautman R., and Harris W.F. Modeling and computer simulation approach to the mechanisms of foot-and-mouth disease virus neutralization assays. Scand J Immunol 6 (1977) 831-841
32. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 20 (1960) 37-46
33. Fleiss J.L., Cohen J., and Everitt B.S. Large sample standard errors of kappa and weighted kappa. Psychol Bull 72 (1969) 323-327
34. Barnett P.V., Statham R.J., Vosloo W., and Haydon D.T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 21 (2003) 3240-3248
35. Mahapatra M., Aggarwal N., Cox S., Statham R.J., Knowles N.J., Barnett P.V., et al. Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains. Vet Microbiol 126 (2008) 40-50
36. Crowther J.R., McCullough K.C., Brocchi E., and De Simone F. Monoclonal antibodies against FMDV: use and potential application. Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of FMD. Brescia, Italy (1984), FAO, Rome 40